Valuation Protagonist Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2026-01-21 EST			5-day change	1st Jan Change
83.89 ^USD	+0.56%		-1.57%	-3.95%

01-13	Protagonist Therapeutics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 08:15 AM
01-05	Takeda and Protagonist Announce Submission of New Drug Application for Rusfertide for Treatment of Polycythemia Vera	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	867.3	1,632	536.8	1,323	2,300	5,215	5,215	-
Change	-	88.21%	-67.12%	146.4%	73.94%	126.69%	0%	-
Enterprise Value (EV) ¹	561.4	1,305	411	1,136	2,203	5,027	4,862	4,836
Change	-	132.51%	-68.51%	176.35%	93.98%	128.14%	-3.27%	-0.53%
P/E ratio	-10.5x	-12.6x	-4.2x	-16.5x	9.13x	-52.3x	127x	-59.7x
PBR	-	-	-	-	-	-	-	-
PEG	-	-0.3x	1.03x	0.4x	-0x	0x	-1x	0x
Capitalization / Revenue	30.3x	59.7x	20.2x	22x	5.3x	78.1x	20x	17.6x
EV / Revenue	19.6x	47.7x	15.5x	18.9x	5.07x	75.2x	18.6x	16.3x
EV / EBITDA	-8.81x	-10.4x	-	-12.3x	8.69x	-34.2x	32.5x	-66.6x
EV / EBIT	-8.7x	-10.4x	-3.13x	-12.1x	8.71x	-39.8x	1,262x	-54.7x
EV / FCF	-7.7x	-12x	-3.77x	-16x	12.1x	61.7x	28.6x	-537x
FCF Yield	-13%	-8.35%	-26.5%	-6.24%	8.3%	1.62%	3.5%	-0.19%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.92	-2.71	-2.6	-1.39	4.23	-1.595	0.6564	-1.397
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	28.63	27.36	26.58	60	434.4	66.81	261	296.2
EBITDA ¹	-63.73	-125	-	-92.68	253.7	-146.9	149.6	-72.59
EBIT ¹	-64.52	-125.8	-131.4	-93.65	252.8	-126.3	3.853	-88.48
Net income ¹	-66.15	-125.6	-127.4	-78.96	275.2	-102.5	24.43	-95.65
Net Debt ¹	-305.8	-326.9	-125.7	-186.7	-97.25	-188.5	-353.1	-379.1
Reference price ²	20.16	34.20	10.91	22.93	38.60	83.42	83.42	83.42
Nbr of stocks (in thousands)	43,019	47,728	49,198	57,678	59,598	62,516	62,516	-
Announcement Date	3/10/21	2/28/22	3/15/23	2/27/24	2/21/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
PROTAGONIST THERAPEUTICS, INC.	-52.31x	75.24x	-34.23x	-	5.22B
LONZA GROUP AG	37.79x	5.5x	18.4x	0.9%	48.34B
IQVIA HOLDINGS INC.	32.91x	3.28x	14.06x	-.--%	39.8B
BEONE MEDICINES AG	102.27x	6.54x	65.78x	-.--%	36.99B
CELLTRION, INC.	54.65x	11.21x	31.16x	0.35%	30.67B
REVOLUTION MEDICINES, INC.	-20.8x	6035.16x	-19.72x	-.--%	22.47B
MEDPACE HOLDINGS, INC.	40.7x	6.6x	29.98x	-.--%	16.97B
Average	27.89x	877.65x	15.06x	0.21%	28.64B
Weighted average by Cap.	42.64x	683.86x	23.57x	0.28%